Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) Debt Ratio (2010 - 2025)

Updated

Xtl Biopharmaceuticals' Debt Ratio came in at 0.83 for the quarter ended Dec 31, 2025, compared with 0.02 a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Debt Ratio (2010 - 2025) Analysis & Trends

Going back to the quarter ended Dec 31, 2010, Xtl Biopharmaceuticals' Debt Ratio data covers 5 quarters.

  • Going back by year, Debt Ratio was 0.02 in the year ended Dec 31, 2024.
  • The figure for the quarter ended Dec 31, 2025 represents the highest quarterly Debt Ratio since the quarter ended Dec 31, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 0.24
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 0.52
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 0.42
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 0.31
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 0.00
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 0.60
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn - 0.83
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 0.83
Dec 31, 2024 0.02
Dec 31, 2017 0.40
Dec 31, 2011 1.00
Dec 31, 2010 1.00
API Access

Xtl Biopharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=XTLB&period=max&api_key=YOUR_API_KEY